aspirin has been researched along with Staphylococcal Infections in 35 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There was a lower rate of catheter-associated S aureus bacteremia in patients treated with aspirin versus those not treated with aspirin (0." | 7.74 | Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. ( Bayer, AS; Cheung, AL; Gemery, JM; Remillard, BD; Sedlacek, M, 2007) |
| " There was a lower rate of catheter-associated S aureus bacteremia in patients treated with aspirin versus those not treated with aspirin (0." | 3.74 | Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. ( Bayer, AS; Cheung, AL; Gemery, JM; Remillard, BD; Sedlacek, M, 2007) |
| "Rhinosinusitis is among the most common infectious complications of humoral immunodeficiency, which is not uncommon in patients with refractory CRS." | 2.46 | Rhinosinusitis and comorbidities. ( Brooks, EG; Ryan, MW, 2010) |
| "Aspirin did not increase bleeding in SA positive patients." | 1.72 | Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis. ( Akhyari, P; Barth, M; Dannenberg, L; Helten, C; Hoffmann, T; Hohlfeld, T; Huhn, R; Kelm, M; Levkau, B; Lichtenberg, A; M'Pembele, R; Mourikis, P; Naguib, D; Petzold, T; Polzin, A; Sixt, S; Zako, S; Zeus, T, 2022) |
| "Severe influenza virus (IV) infections still represent a major challenge to public health." | 1.56 | The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections. ( Deinhardt-Emmer, S; Ehrhardt, C; Gieselmann, L; Haupt, KF; Hrincius, ER; Ludwig, S; Niemann, S; Preugschas, HF; van Krüchten, A; Wilden, JJ, 2020) |
| "Aspirin was injected intraperitoneally twice daily for 11 days." | 1.51 | Aspirin alleviates orthopedic implant‑associated infection. ( Jiang, Y; Lin, JC; Qin, HJ; Ren, ML; Wang, SN; Wu, HT; Yu, B, 2019) |
| "Aspirin sensitivity was associated with increased concentrations of eosinophil-related mediators, as well as IgE antibodies to SAEs in nasal polyp tissue." | 1.32 | Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. ( Bachert, C; Gevaert, P; Holtappels, G; Johannson, S; Kowalski, ML; Kuna, P; Pérez-Novo, CA; Ptasinska, A; van Cauwenberge, P, 2004) |
| " We sought to determine (i) whether ASA dosage influences the development of vegetations and (ii) whether ASA given with antimicrobial therapy improves the treatment outcome of infective endocarditis." | 1.29 | Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. ( Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (31.43) | 18.7374 |
| 1990's | 3 (8.57) | 18.2507 |
| 2000's | 9 (25.71) | 29.6817 |
| 2010's | 8 (22.86) | 24.3611 |
| 2020's | 4 (11.43) | 2.80 |
| Authors | Studies |
|---|---|
| Polzin, A | 1 |
| Dannenberg, L | 1 |
| M'Pembele, R | 1 |
| Mourikis, P | 1 |
| Naguib, D | 1 |
| Zako, S | 1 |
| Helten, C | 1 |
| Petzold, T | 1 |
| Levkau, B | 1 |
| Hohlfeld, T | 1 |
| Barth, M | 1 |
| Zeus, T | 1 |
| Sixt, S | 1 |
| Huhn, R | 1 |
| Akhyari, P | 1 |
| Lichtenberg, A | 1 |
| Kelm, M | 1 |
| Hoffmann, T | 1 |
| Jiang, Y | 1 |
| Wang, SN | 1 |
| Wu, HT | 1 |
| Qin, HJ | 1 |
| Ren, ML | 1 |
| Lin, JC | 1 |
| Yu, B | 1 |
| Carestia, A | 1 |
| Davis, RP | 1 |
| Grosjean, H | 1 |
| Lau, MW | 1 |
| Jenne, CN | 1 |
| Wilden, JJ | 1 |
| van Krüchten, A | 1 |
| Gieselmann, L | 1 |
| Hrincius, ER | 1 |
| Deinhardt-Emmer, S | 1 |
| Haupt, KF | 1 |
| Preugschas, HF | 1 |
| Niemann, S | 1 |
| Ludwig, S | 1 |
| Ehrhardt, C | 1 |
| Okada, Y | 1 |
| Kimura, F | 1 |
| Chabert, A | 1 |
| Damien, P | 1 |
| Verhoeven, PO | 1 |
| Grattard, F | 1 |
| Berthelot, P | 1 |
| Zeni, F | 1 |
| Panicot-Dubois, L | 1 |
| Robert, S | 1 |
| Dignat-George, F | 1 |
| Eyraud, MA | 1 |
| Pozzetto, B | 1 |
| Payrastre, B | 1 |
| Cognasse, F | 1 |
| Garraud, O | 1 |
| Hamzeh-Cognasse, H | 1 |
| Longhurst, WD | 1 |
| Sheele, JM | 1 |
| Osthoff, M | 1 |
| Sidler, JA | 1 |
| Lakatos, B | 1 |
| Frei, R | 1 |
| Dangel, M | 1 |
| Weisser, M | 1 |
| Battegay, M | 1 |
| Widmer, AF | 1 |
| Das, UN | 1 |
| Eisen, DP | 2 |
| Corey, GR | 1 |
| McBryde, ES | 1 |
| Fowler, VG | 1 |
| Miro, JM | 1 |
| Cabell, CH | 1 |
| Street, AC | 1 |
| Paiva, MG | 1 |
| Ionac, A | 1 |
| Tan, RS | 1 |
| Tribouilloy, C | 1 |
| Pachirat, O | 1 |
| Jones, SB | 1 |
| Chipigina, N | 1 |
| Naber, C | 1 |
| Pan, A | 1 |
| Ravasio, V | 1 |
| Gattringer, R | 1 |
| Chu, VH | 1 |
| Bayer, AS | 3 |
| Ryan, MW | 1 |
| Brooks, EG | 1 |
| Mekni, MA | 1 |
| Achour, W | 1 |
| Ben Hassen, A | 1 |
| Meimoun, P | 1 |
| Mainardi, JL | 1 |
| Berrebi, A | 1 |
| Marino, JP | 1 |
| Waldmann, T | 1 |
| Carpentier, A | 1 |
| HEDWALL, P | 1 |
| HEEG, E | 1 |
| ABU-NASSAR, HJ | 1 |
| YOW, EM | 1 |
| ALEXANDER, JK | 1 |
| LEWIS, JM | 1 |
| HARRISON, KJ | 1 |
| DUPONT, V | 1 |
| MARGAIRAZ, A | 1 |
| GOGUEL, A | 1 |
| Pérez-Novo, CA | 1 |
| Kowalski, ML | 1 |
| Kuna, P | 1 |
| Ptasinska, A | 1 |
| Holtappels, G | 2 |
| van Cauwenberge, P | 2 |
| Gevaert, P | 2 |
| Johannson, S | 1 |
| Bachert, C | 2 |
| Van Zele, T | 1 |
| Watelet, JB | 1 |
| Claeys, G | 1 |
| Claeys, C | 1 |
| Karabay, O | 2 |
| Arinc, H | 1 |
| Gunduz, H | 1 |
| Tamer, A | 1 |
| Ozhan, H | 1 |
| Uyan, C | 1 |
| Sedlacek, M | 1 |
| Gemery, JM | 1 |
| Cheung, AL | 1 |
| Remillard, BD | 1 |
| Demirag, MK | 1 |
| Esen, S | 1 |
| Zivalioglu, M | 1 |
| Leblebicioglu, H | 1 |
| Keceligil, HT | 1 |
| Yildirim, M | 1 |
| Ozdemir, D | 1 |
| Lowney, ED | 1 |
| Baublis, JV | 1 |
| Kreye, GM | 1 |
| Harrell, ER | 1 |
| McKenzie, AR | 1 |
| Nicolau, DP | 2 |
| Marangos, MN | 1 |
| Nightingale, CH | 2 |
| Quintiliani, R | 1 |
| Tessier, PR | 1 |
| Kupferwasser, LI | 1 |
| Yeaman, MR | 1 |
| Shapiro, SM | 1 |
| Nast, CC | 1 |
| Sullam, PM | 1 |
| Filler, SG | 1 |
| Chan, L | 1 |
| Chinnock, B | 1 |
| Schlossberg, D | 1 |
| Kandra, J | 1 |
| Kreiser, J | 1 |
| Schreiner, GE | 1 |
| Saraiva, LR | 1 |
| Menge, P | 1 |
| Rodrigues, R | 1 |
| de França, NA | 1 |
| Barros, GS | 1 |
| Brindeiro Filho, D | 1 |
| Sevitt, S | 1 |
| Stone, P | 1 |
| Jackson, D | 1 |
| Baar, S | 1 |
| Pollock, A | 1 |
| Miller, GC | 1 |
| Witham, AC | 1 |
| Van Reken, D | 1 |
| Strauss, A | 1 |
| Hernandez, A | 1 |
| Feigin, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter Randomized, Double-blind, Placebo-controlled, Clinical Trial of Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients (Asperum)[NCT04808895] | Phase 3 | 204 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Role of Doxycycline in the Management of Patients With Chronic Rhinosinusitis With Nasal Polyps[NCT05157412] | Phase 3 | 60 participants (Anticipated) | Interventional | 2022-03-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for aspirin and Staphylococcal Infections
| Article | Year |
|---|---|
Rhinosinusitis and comorbidities.
Topics: Anti-Bacterial Agents; Aspirin; Cystic Fibrosis; Humans; Hypersensitivity; Immunity, Humoral; Immuno | 2010 |
Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Animal; Dose-Response Rel | 2012 |
33 other studies available for aspirin and Staphylococcal Infections
| Article | Year |
|---|---|
Staphylococcus aureus increases platelet reactivity in patients with infective endocarditis.
Topics: Aspirin; Coagulase; Cohort Studies; Endocarditis, Bacterial; Humans; Pilot Projects; Platelet Aggreg | 2022 |
Aspirin alleviates orthopedic implant‑associated infection.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Models, Animal; Female; Humans; I | 2019 |
Acetylsalicylic acid inhibits intravascular coagulation during Staphylococcus aureus-induced sepsis in mice.
Topics: Animals; Aspirin; Blood Coagulation; Disseminated Intravascular Coagulation; Mice; Mice, Inbred C57B | 2020 |
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections.
Topics: A549 Cells; Antiviral Agents; Aspirin; Bacterial Infections; Drug Combinations; Epithelial Cells; Ge | 2020 |
Multiple aortic thrombi in essential thrombocythaemia.
Topics: Aged; Aorta, Abdominal; Aspirin; Cefazolin; Echocardiography; Heparin; Humans; Hydroxyurea; Male; St | 2021 |
Acetylsalicylic acid differentially limits the activation and expression of cell death markers in human platelets exposed to Staphylococcus aureus strains.
Topics: Aspirin; Bacterial Adhesion; Biomarkers; Blood Platelets; Cell Death; Humans; Platelet Activation; P | 2017 |
Spontaneous methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Cerebellum; Female; Humans; Meningitis, Ba | 2018 |
Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacteremia; Cross Infection; Escherichia co | 2016 |
Low-Dose Acetylsalicylic Acid and Short-Term Mortality in Staphylococcus aureus Bloodstream Infection.
Topics: Aspirin; Bacteremia; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Staphyloc | 2016 |
Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid.
Topics: Aged; Aspirin; Cohort Studies; Embolism; Endocarditis, Bacterial; Female; Heart Failure; Heart Valve | 2009 |
Comment on the effect of aspirin on adherence of slime-producing, coagulase-negative Staphylococci to vascular grafts.
Topics: Aspirin; Bacterial Adhesion; Blood Vessel Prosthesis; Humans; Prosthesis-Related Infections; Staphyl | 2012 |
[Staphylococcus epidermidis infective endocarditis after mitral surgery, successfully treated with aspirin and antibiotics: a case report].
Topics: Adult; Anti-Bacterial Agents; Aspirin; Endocarditis, Bacterial; Female; Humans; Mitral Valve; Platel | 2000 |
[Modification of staphylococcal infections of the rat kidney by analgesics].
Topics: Analgesics; Animals; Aspirin; Kidney Diseases; Phenacetin; Rats; Staphylococcal Infections | 1961 |
PRIMARY STAPHYLOCOCCAL PERICARDITIS COMPLICATING CARDIOTOMY: A REPORT OF A CASE WITH A NOTE ON INTRAPERICARDIAL METHICILLIN THERAPY.
Topics: Aspirin; Bacterial Infections; Cardiac Surgical Procedures; Methicillin; Penicillins; Pericarditis; | 1964 |
BOILS; THEIR TREATMENT AND PREVENTION.
Topics: Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Antipyretics; Aspirin; Bandage | 1964 |
[SOME EXAMPLES OF "PSEUDO-INFECTIOUS" PICTURES INDUCED BY DRUGS].
Topics: Adolescent; Anticonvulsants; Arsenicals; Aspirin; Barbiturates; Diagnosis, Differential; Drug Erupti | 1964 |
Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Proteins; Bronchial Provocation Tests | 2004 |
Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.
Topics: Adult; Aspirin; Asthma; Chronic Disease; Drug Hypersensitivity; Enterotoxins; Female; Humans; Immuno | 2004 |
A new effect of acetylsalicylic acid? Significantly lower prevalence of nasal carriage of Staphylococcus aureus among patients receiving orally administered acetylsalicylic acid.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carrier State; Female; Human | 2006 |
Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aspirin; Bacteremia; Catheters, Indwelling; F | 2007 |
The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts.
Topics: Aspirin; Bacterial Adhesion; Blood Vessel Prosthesis; Coagulase; Colony Count, Microbial; Humans; Po | 2007 |
Decreasing risk of Staphylococcus aureus infections.
Topics: Aspirin; Humans; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2007 |
The scalded skin syndrome in small children.
Topics: Aspirin; Child, Preschool; Erythema Multiforme; Female; Humans; Infant; Infant, Newborn; Male; Penic | 1967 |
Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Bacterial Agents; Aorta; Aspirin; Dose-Response Relationship, Drug; Endocarditis, Bact | 1995 |
Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Aspirin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Platelet Aggregation I | 1999 |
Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Colony Count, Microbial; Embolism; Endocarditis, Bacterial; | 1999 |
Clinicopathological conference: multisystem failure in a child.
Topics: Anti-Bacterial Agents; Aspirin; Child; Clindamycin; Female; Humans; Immunoglobulins, Intravenous; Mu | 2000 |
Possible Kawasaki disease in a 20-year-old woman.
Topics: Adult; Age Factors; Aspirin; Diagnosis, Differential; Erythromycin; Female; Humans; Lymphatic Diseas | 1979 |
Drug-related nephropathy.
Topics: Analgesics; Aspirin; Heroin Dependence; Humans; Inulin; Kidney; Kidney Cortex Necrosis; Kidney Disea | 1978 |
[Evolutive aspect of the echocardiographic image of the vegetation in tricuspid valve endocarditis cured with clinical treatment. A case report].
Topics: Aspirin; Cefotaxime; Child; Echocardiography; Endocarditis, Bacterial; Gentamicins; Humans; Male; St | 1988 |
Acute Heinz-body anaemia in burned patients.
Topics: Adult; Ampicillin; Anemia, Hemolytic; Aspirin; Burns; Carbenicillin; Cloxacillin; Digoxin; Erythrocy | 1973 |
Delayed febrile pleuropericarditis after sepsis. A possible analogue of the postcardiotomy syndrome.
Topics: Adult; Aspirin; Blood Sedimentation; Cardiomegaly; Erythrocytes; Female; Fever; Heart Auscultation; | 1973 |
Infectious pericarditis in children.
Topics: Adenoviridae Infections; Adolescent; Ampicillin; Aortic Aneurysm; Aspirin; Bacterial Infections; Chi | 1974 |